Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 6:28 PM View:  | Shenouda Maged Chief Financial Officer | Relmada Therapeutics, Inc. (RLMD) | 31-Jan-24 | Purchase | 6,875 | $4.06 | $27,943.40 | 25% 28.03K to 34.9K | |
| 31-Jan-24 6:28 PM View: | Ence Chuck CA and CO | Relmada Therapeutics, Inc. (RLMD) | 31-Jan-24 | Purchase | 13,670 | $4.05 | $55,429.10 | 54% 25.3K to 38.97K | |
| 31-Jan-24 6:29 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 31-Jan-24 | Purchase | 27,460 | $4.00 | $109,752.00 | 13% 216.56K to 244.02K | |
| 31-Jan-24 6:29 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 30-Jan-24 | Purchase | 40,999 | $3.90 | $159,949.00 | 23% 175.56K to 216.56K | |
| 31-Jan-24 6:28 PM View: | Shenouda Maged Chief Financial Officer | Relmada Therapeutics, Inc. (RLMD) | 30-Jan-24 | Purchase | 15,000 | $3.89 | $58,323.00 | 115% 13.03K to 28.03K | |
| 31-Jan-24 6:28 PM View: | Ence Chuck CA and CO | Relmada Therapeutics, Inc. (RLMD) | 30-Jan-24 | Purchase | 14,500 | $3.87 | $56,052.60 | 134% 10.8K to 25.3K | |
| 31-Jan-24 6:29 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 29-Jan-24 | Private Purchase | 31,541 | $3.71 | $117,036.00 | 22% 144.02K to 175.56K | |
| 31-Jan-24 6:28 PM View: | Shenouda Maged Chief Financial Officer | Relmada Therapeutics, Inc. (RLMD) | 29-Jan-24 | Private Purchase | 10,800 | $3.65 | $39,450.20 | 485% 2.23K to 13.03K | |
| 31-Jan-24 6:28 PM View: | Ence Chuck CA and CO | Relmada Therapeutics, Inc. (RLMD) | 29-Jan-24 | Private Purchase | 10,800 | $3.65 | $39,438.40 | 100% 0 to 10.8K | |
| 24-May-23 9:00 AM View: | O'Gorman Cedric Chief Medical Officer | Relmada Therapeutics, Inc. (RLMD) | 23-May-23 | Private Purchase | 10,000 | $3.18 | $31,800.00 | 8264% 0.12K to 10.12K | |
| 12-Dec-22 8:00 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 08-Dec-22 | Private Purchase | 55,250 | $2.10 | $115,804.00 | 62% 88.77K to 144.02K | |
| 05-Jul-22 4:30 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 01-Jul-22 | Option Exercise | 13,755 | $16.00 | $220,080.00 | 15% 88.77K to 102.53K | |
| 05-Jul-22 4:30 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 01-Jul-22 | Option Sale | 13,755 | $18.41 | $253,276.00 | (13%) 102.53K to 88.77K | |
| 05-Jul-22 4:30 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 30-Jun-22 | Option Exercise | 16,012 | $16.00 | $256,192.00 | 18% 88.77K to 104.79K | |
| 05-Jul-22 4:30 PM View: | Traversa Sergio Chief Executive Officer Director | Relmada Therapeutics, Inc. (RLMD) | 30-Jun-22 | Option Sale | 16,012 | $19.13 | $306,301.00 | (15%) 104.79K to 88.77K | |
| 05-Apr-22 5:34 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 04-Apr-22 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 5% 187.29K to 197.29K | |
| 05-Apr-22 5:34 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 04-Apr-22 | Planned Option Sale | 10,000 | $30.04 | $300,395.00 | (5%) 197.29K to 187.29K | |
| 05-Apr-22 5:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-22 | Planned Option Sale | 19,800 | $29.00 | $574,200.00 | (100%) 19.8K to 0 | |
| 05-Apr-22 5:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-22 | Option Exercise | 19,800 | $3.24 | $64,152.00 | 100% 0 to 19.8K | |
| 05-Jan-22 5:01 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 03-Jan-22 | Option Exercise | 20,000 | $3.24 | $64,800.00 | (10%) 207.29K to 187.29K | |
| 02-Feb-23 10:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 03-Dec-21 | Gift | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 02-Feb-23 10:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 03-Dec-21 | Gift | 10,000 | -- | -- | (50%) 20.0K to 10.0K | |
| 24-Sep-21 10:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 22-Sep-21 | Option Exercise | 10,000 | $4.60 | $46,000.00 | 152% 6.6K to 16.6K | |
| 24-Sep-21 10:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 22-Sep-21 | Market Option Sale (Planned) | 6,600 | $29.00 | $191,400.00 | (40%) 16.6K to 10.0K | |
| 19-Aug-21 5:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 17-Aug-21 | Option Exercise | 10,000 | $4.60 | $46,000.00 | 213% 4.7K to 14.7K | |
| 16-Jul-21 10:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 15-Jul-21 | Market Sale (Planned) | 3,300 | $31.54 | $104,088.00 | (41%) 8.0K to 4.7K | (< 1%) |
| 02-Jun-21 5:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 01-Jun-21 | Market Sale (Planned) | 3,000 | $33.34 | $100,020.00 | (30%) 9.95K to 6.95K | 3% |
| 05-May-21 5:00 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 03-May-21 | Market Sale (Planned) | 3,000 | $38.22 | $114,647.00 | (23%) 12.95K to 9.95K | < 1% |
| 05-Apr-21 4:08 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-21 | Market Sale (Planned) | 3,000 | $35.43 | $106,281.00 | (19%) 15.95K to 12.95K | (3%) |
| 10-Mar-21 6:18 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 10-Mar-21 | Market Option Sale (Planned) | 2,373 | $35.11 | $83,313.40 | (52%) 4.6K to 2.23K | |
| 11-Mar-21 5:51 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 10-Mar-21 | Market Option Sale | 2,983 | $35.09 | $104,676.00 | (3%) 91.76K to 88.77K | |
| 11-Mar-21 5:51 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 11% 88.77K to 98.77K | |
| 11-Mar-21 5:51 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Market Option Sale | 7,017 | $35.65 | $250,169.00 | (7%) 98.77K to 91.76K | |
| 11-Mar-21 5:50 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Market Option Sale | 5,000 | $35.71 | $178,551.00 | (3%) 172.29K to 167.29K | |
| 11-Mar-21 5:50 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Option Exercise | 5,000 | $3.24 | $16,200.00 | 3% 167.29K to 172.29K | |
| 10-Mar-21 6:18 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 09-Mar-21 | Market Option Sale (Planned) | 7,527 | $35.56 | $267,693.00 | (62%) 12.13K to 4.6K | |
| 10-Mar-21 6:18 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 08-Mar-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 449% 2.23K to 12.23K | |
| 10-Mar-21 6:18 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 08-Mar-21 | Market Option Sale (Planned) | 100 | $35.00 | $3,500.00 | (< 1%) 12.23K to 12.13K | |
| 02-Mar-21 4:08 PM View: | Casamento Charles J Director | Relmada Therapeutics, Inc. (RLMD) | 01-Mar-21 | Market Sale (Planned) | 3,000 | $33.87 | $101,618.00 | (16%) 18.95K to 15.95K | < 1% |
| 26-Feb-21 4:48 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Market Option Sale (Planned) | 3,000 | $34.18 | $102,529.00 | (57%) 5.23K to 2.23K | |
| 26-Feb-21 4:49 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Option Exercise | 5,000 | $3.24 | $16,200.00 | 3% 167.29K to 172.29K | |
| 26-Feb-21 4:50 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Option Exercise | 10,000 | $3.24 | $32,400.00 | 11% 88.77K to 98.77K | |
| 26-Feb-21 4:50 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Market Option Sale | 10,000 | $34.24 | $342,392.00 | (10%) 98.77K to 88.77K | |
| 26-Feb-21 4:49 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Market Option Sale | 5,000 | $34.19 | $170,933.00 | (3%) 172.29K to 167.29K | |
| 26-Feb-21 4:48 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 24-Feb-21 | Option Exercise | 3,000 | $3.24 | $9,720.00 | 135% 2.23K to 5.23K | |
| 17-Feb-21 6:37 PM View: | Kelly Paul Edward Director | Relmada Therapeutics, Inc. (RLMD) | 16-Feb-21 | Option Exercise | 5,000 | $6.00 | $30,000.00 | 3% 162.29K to 167.29K | |
| 16-Feb-21 5:10 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Option Exercise | 1,446 | $3.24 | $4,685.04 | 2% 88.77K to 90.22K | |
| 16-Feb-21 5:10 PM View: | Traversa Sergio CEO Director | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Market Option Sale | 1,446 | $35.43 | $51,238.40 | (2%) 90.22K to 88.77K | |
| 16-Feb-21 5:08 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Option Exercise | 1,428 | $3.24 | $4,626.72 | 64% 2.23K to 3.66K | |
| 16-Feb-21 5:08 PM View: | Shenouda Maged CFO | Relmada Therapeutics, Inc. (RLMD) | 11-Feb-21 | Market Option Sale (Planned) | 1,428 | $35.39 | $50,542.10 | (39%) 3.66K to 2.23K |
